LibraryNeurology· 119 of 132
Neurology

Temporal Lobe Epilepsy

~15 min read8 sections
⭐ High-yield🎯 Drill Neurology
Contents (8)

Temporal lobe epilepsy (TLE) is the most common form of focal (localization-related) epilepsy in adults, arising from abnormal neuronal discharges originating in the temporal lobe, typically the medial temporal structures (hippocampus, amygdala, and entorhinal cortex). TLE accounts for approximately 40% of all focal seizures and up to 80% of surgically remediable epilepsy cases, making it clinically significant for both medical management and potential surgical intervention. The disorder predominantly affects adolescents and adults, with peak onset in the second and third decades of life, though childhood-onset forms are well-described. TLE is characterized by a chronic, unprovoked course with partial seizures that frequently secondarily generalize, often featuring distinctive auras and automatisms that aid in clinical diagnosis. Understanding the pathophysiology, imaging characteristics, and pharmacological management of TLE is essential for board examinations and clinical practice, particularly given the high seizure burden in affected patients and the unique opportunity for curative surgical intervention in drug-resistant cases.

The pathophysiology of TLE involves complex interactions between structural, genetic, and functional abnormalities centered on the medial temporal lobe structures. The classic "two-hit" model proposes an initial precipitating injury (first hit) that triggers a period of epileptogenesis (months to years), culminating in the development of a hyperexcitable network (second hit) capable of spontaneous recurrent seizures.

- Mesial temporal sclerosis (MTS) and hippocampal damage: The most common structural abnormality in TLE is mesial temporal sclerosis (MTS), characterized by selective neuronal loss in the hippocampus, particularly affecting the CA1 and CA3 regions while sparing the dentate gyrus. This pattern of selective vulnerability results from prolonged excitotoxicity and calcium influx through N-methyl-D-aspartate (NMDA) and AMPA receptors. The excitotoxic cascade involves excessive glutamate release during prolonged seizures or status epilepticus, which binds NMDA receptors, triggering calcium influx that activates proteases, endonucleases, and mitochondrial dysfunction, ultimately leading to neuronal death. MTS is associated with initial precipitating injuries such as prolonged febrile seizures (the "febrile seizure-to-TLE" pathway), severe head trauma, or status epilepticus in childhood. The resulting neuronal loss disrupts the inhibitory circuits of the hippocampus, creating an imbalance between excitatory and inhibitory neurotransmission that promotes seizure generation. The hippocampus normally functions to inhibit excessive temporal lobe activity; when damaged, this inhibitory capacity is compromised, permitting hyperexcitability to develop and propagate.

- Network hyperexcitability and aberrant sprouting: Following the initial injury, surviving neurons undergo structural and functional reorganization through a process called mossy fiber sprouting and granule cell dispersion. Dentate granule cells normally receive inhibitory input from basket cells; following injury, aberrant recurrent connections develop between granule cells themselves through sprouting of mossy fibers (axons from dentate granule cells), creating a recurrent excitatory circuit that can sustain epileptic activity. This sprouting occurs over weeks to months and represents a key step in the transition from a normal brain to one capable of spontaneous seizures. Additionally, granule cell layer dispersion (blurring of the normal tight organization) occurs, contributing to the disruption of local inhibitory circuits. These anatomical changes are accompanied by functional alterations in GABAergic (inhibitory) and glutamatergic (excitatory) neurotransmission, including reduced expression of GABA receptor subunits (particularly α1 and α5) and enhanced AMPA receptor trafficking to neuronal membranes, further shifting the excitation-inhibition balance toward hyperexcitability.

- Impaired GABAergic inhibition: The loss of inhibitory interneurons and dysfunction of GABA receptor signaling are critical mechanisms in TLE pathophysiology. In MTS, there is a selective and severe loss of GABA-producing interneurons, particularly parvalbumin-positive basket cells and chandelier cells that normally provide perisomatic inhibition to pyramidal neurons. The remaining GABAergic neurons show reduced expression of GABA-synthesizing enzymes (glutamic acid decarboxylase, GAD) and altered GABA receptor subunit composition. Furthermore, during the chronic epileptic state, there is a paradoxical depolarizing shift in the GABA reversal potential (EGABA) in some neurons due to altered chloride homeostasis (reduced KCC2 expression and increased NKCC1 expression), meaning that GABA activation may paradoxically depolarize rather than hyperpolarize neurons, reducing its inhibitory efficacy. This explains why some patients with TLE may show paradoxical responses to benzodiazepines or have reduced seizure suppression despite adequate GABAergic drug levels.

- Enhanced excitatory glutamatergic signaling: Counterbalancing the loss of inhibition is an increase in excitatory glutamatergic neurotransmission. Surviving pyramidal neurons develop increased numbers of AMPA and NMDA receptors, and there is upregulation of metabotropic glutamate receptors (mGluRs), particularly Group I mGluRs (mGluR1 and mGluR5), which couple to intracellular calcium release and further amplify excitatory signaling. Enhanced AMPA receptor trafficking to the postsynaptic membrane increases the sensitivity of neurons to glutamate, while changes in NMDA receptor subunit composition (shift toward GluN2B-containing receptors) prolongs the duration of excitatory postsynaptic currents. These changes collectively increase network excitability and lower the seizure threshold.

- Alterations in ion channel function: Mutations and functional changes in voltage-gated and ligand-gated ion channels contribute to TLE pathophysiology. Reduced potassium channel function (particularly Kv1.1 and Kv4.2 channels) impairs the repolarization phase of action potentials and limits the ability of neurons to maintain resting membrane potential, making them more likely to fire repetitively. Conversely, there may be enhanced persistent sodium current (INaP), allowing inward sodium flow that depolarizes neurons more readily. These channelopathies are particularly important in genetic forms of TLE and contribute to the chronic hyperexcitable state.

- Loss of dentate gyrus inhibition and disrupted feedback circuits: The normal hippocampus possesses powerful feedback inhibition mechanisms; the dentate gyrus receives excitatory input from the entorhinal cortex but processes it through local GABAergic circuits before transmitting it to CA3. In TLE, this "gate-keeping" function is compromised due to loss of inhibitory interneurons and increased recurrent excitation among granule cells. The result is that excitatory signals propagate unchecked through the hippocampal circuit, initiating seizures that may then spread to other brain regions.

- Molecular inflammatory cascade: Emerging evidence indicates that chronic neuroinflammation contributes to TLE pathogenesis. Microglial activation and astrocytic gliosis are prominent in MTS tissue, leading to elevated production of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) that can potentiate neuronal excitability through direct effects on ion channels and glutamate transporters. Toll-like receptor (TLR) signaling is upregulated, perpetuating the inflammatory state. High-mobility group box 1 (HMGB1) and other danger-associated molecular patterns (DAMPs) released from damaged neurons activate TLRs, creating a self-sustaining cycle of inflammation that may resist conventional anti-seizure medications.

- Initial precipitating injury and the febrile seizure pathway: Prolonged febrile seizures (lasting >15 minutes or occurring in clusters) in infancy or early childhood represent the most common identified risk factor for developing TLE, occurring in up to 30-40% of patients with drug-resistant TLE and MTS. The mechanism involves excitotoxic injury to the hippocampus during the period of hyperthermia-induced seizure activity, with subsequent epileptogenesis developing over months to years. Brief febrile seizures (<5 minutes) carry minimal long-term epilepsy risk, but the duration and severity of initial febrile seizures correlate with subsequent TLE development. This pathway is thought to account for the majority of acquired MTS cases.

- Status epilepticus and severe head trauma: Prolonged or repetitive seizures (status epilepticus), particularly if occurring in childhood, can trigger hippocampal damage and subsequent TLE development. Similarly, significant closed head injury with loss of consciousness or diffuse axonal injury increases TLE risk substantially (relative risk 5-15 times higher than general population). The temporal relationship between head trauma and seizure onset typically ranges from months to several years, consistent with an epileptogenesis period.

- Brain lesions and focal pathology (lesional TLE): Structural lesions within the temporal lobe substantially increase seizure risk. These include:

  • Hippocampal sclerosis/MTS (discussed above): the most common pathological finding
  • Developmental cortical abnormalities (focal cortical dysplasia, heterotopias, polymicrogyria) in the temporal lobe
  • Tumor or mass lesions (low-grade gliomas, gangliogliomas, hamartomas): chronic irritation of cortex promotes seizure development
  • Arteriovenous malformations (AVMs) in temporal lobe
  • Stroke or ischemic injury to temporal lobe structures

- Genetic predisposition and familial TLE: Although most TLE cases appear sporadic, approximately 5-10% of patients report a family history of seizures, suggesting genetic contribution. Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) and some generalized epilepsy syndromes can present with temporal lobe features. More commonly, TLE involves polygenic inheritance with multiple susceptibility loci, rather than single-gene Mendelian inheritance. Genome-wide association studies (GWAS) have identified susceptibility loci associated with increased TLE risk, though the functional significance of most variants remains unclear. Certain single-gene mutations in ion channel genes (LGI1, GRIN2B, DEPDC5) have been identified in familial TLE.

- Infections and inflammation: Prior central nervous system infections substantially increase TLE risk, particularly:

  • Meningitis or encephalitis (especially viral, including HSV-1): can cause acute temporal lobe inflammation and subsequent scarring
  • Neurocysticercosis (in endemic regions): tapeworm larvae colonizing temporal lobe trigger inflammation and calcification
  • Tuberculosis meningitis: causes chronic inflammation and potential vasculitis affecting temporal structures
  • These infections presumably cause seizures through both acute inflammation and chronic gliotic changes.

- Psychiatric and substance use factors: Patients with depression, anxiety, or substance use disorders (particularly alcohol dependence) have higher TLE incidence, though the direction of causality is often unclear (e.g., depression may be a consequence of chronic seizures rather than a risk factor). Chronic alcohol use may promote seizures through effects on GABAergic neurotransmission and brain pathology.

- Aura (focal onset symptoms): The vast majority (70-80%) of TLE seizures begin with an aura, a brief stereotyped focal symptom arising from seizure activity restricted to a limited brain region before generalization or secondary spread occurs. Auras are subjective experiences that the patient remembers and can describe, distinguishing them from automatisms. Common auras in TLE include:

  • Epigastric aura (most common in mesial TLE): a rising sensation in the epigastrium or abdomen, often described as butterflies, tingling, or a "wave" sensation, occurring in ~40% of TLE patients
  • Emotional auras: sudden intense fear, anxiety, or occasionally déjà vu (feeling of familiarity with novel situation) or jamais vu (unfamiliarity with known situation), thought to arise from amygdaloid seizure activity
  • Psychic auras: altered perception of self, surroundings, or time; autoscopic hallucinations (seeing oneself from outside the body)
  • Olfactory or gustatory hallucinations: particularly common with lateral temporal lobe origin, often unpleasant (burning, foul odors)
  • Auditory hallucinations: buzzing, humming, or more complex sounds
  • Autonomic auras: palpitations, flushing, piloerection, urinary urgency

The aura typically lasts 10-60 seconds and may serve as a warning allowing the patient to seek safety before loss of awareness.

- Impaired awareness and automatisms (seizure proper): Following the aura, the patient experiences impaired consciousness (loss of awareness or responsiveness), which may occur abruptly or evolve over several seconds. This reflects spread of seizure activity from medial temporal structures to broader networks affecting arousal and consciousness. Simultaneously or immediately after consciousness is impaired, patients exhibit automatisms—purposeless, repetitive motor behaviors that represent semipurposeful movements during altered awareness:

  • Oral automatisms: lip smacking, tongue protrusion, chewing, swallowing
  • Manual automatisms: hand picking, fidgeting, picking at clothes
  • Gestural automatisms: pointing, reaching, pedaling motions
  • Ambulatory automatisms: ambulating (less common), pacing

Automatisms reflect the spread of seizure activity to adjacent temporal and frontal structures; their nature may provide clues to seizure lateralization (e.g., unilateral manual automatisms suggest contralateral seizure focus). Automatisms typically last 30 seconds to 2 minutes.

- Postictal confusion and symptoms: Following seizure cessation, patients typically experience a prolonged postictal state (distinguishing TLE from primary generalized seizures, which have brief postictal periods) characterized by:

  • Postictal confusion or disorientation lasting 10-30 minutes or longer
  • Fatigue and drowsiness lasting hours
  • Postictal headache (common)
  • Postictal psychosis (rare but notable: florid hallucinations, delusions, or bizarre behavior occurring minutes to hours after seizure, typically resolving within 48 hours)
  • Postictal nausea or vomiting
  • Postictal weakness (Todd's paralysis): transient focal weakness in limb contralateral to seizure focus, lasting minutes to hours, caused by postictal neuronal depression

- Secondary generalization: In many patients (40-60% of TLE cases), partial seizures secondarily generalize to generalized tonic-clonic seizures, characterized by loss of consciousness and generalized convulsive activity. The transition from focal seizure to secondary generalization typically occurs within 30-60 seconds of seizure onset. The progression from focal to generalized seizure reflects propagation of seizure activity from the temporal lobe focus to the opposite hemisphere and deeper brain structures (thalamus, brainstem).

- Frequency and temporal patterns: TLE seizures often occur in clusters (multiple seizures over hours to days) but may also occur as isolated events. Seizures in TLE are unprovoked (occurring without obvious trigger) and recurrent (repeated episodes, typically several times per month if untreated, though this is highly variable). Some patients report circadian patterns with increased seizure likelihood at particular times of day or sleep stage.

- Behavioral and psychiatric manifestations: Beyond seizures themselves, TLE patients frequently experience:

  • Interictal behavioral abnormalities: irritability, aggression, impulsive behavior
  • Depression and anxiety: present in up to 40% of TLE patients, may precede seizure onset or develop secondary to chronic seizure disorder
  • Interictal dysphoria: dysphoric mood (depressed or anxious) between seizures
  • Cognitive impairment: memory difficulties, slowed processing, reduced executive function, particularly with left-sided seizure foci affecting verbal memory
  • Personality changes: described as "temporal lobe personality" with viscosity (tendency toward prolonged, circumstantial speech) and deepened emotional responses, though this is nonspecific

- Neurological examination findings: The interictal neurological examination is often normal in uncomplicated TLE without significant brain pathology. However, specific findings may be present:

  • Impaired memory function on cognitive testing, particularly contralateral to seizure focus
  • Subtle motor or sensory abnormalities if significant structural lesion present
  • Aphasia (typically expressive) if left temporal lobe involved
  • Visual field defects (superior quadrantanopia) if temporal lobe pathology affects optic radiations
  • Facial weakness occasionally seen, typically contralateral to seizure focus

- Clinical history and seizure semiology: The diagnostic approach begins with **detailed history

Acute seizure / status epilepticus (emergency)

  • Airway, lateral decubitus positioning, glucose and timing: any focal seizure with impaired awareness lasting ≥5 minutes, or repeated seizures without recovery, is treated as status epilepticus per the American Epilepsy Society (AES) 2016 guideline.
  • Benzodiazepines (first line): lorazepam 4 mg IV (may repeat) or midazolam 10 mg IM if no IV access; they enhance GABA-A chloride conductance, though efficacy falls as seizures persist because synaptic GABA-A receptors internalize.
  • Second-phase ASM: IV fosphenytoin, valproate, or levetiracetam — the ESETT trial found no difference among them.

Chronic maintenance therapy

  • Sodium-channel blockers: carbamazepine, oxcarbazepine, lacosamide, or lamotrigine slow recovery of voltage-gated Na⁺ channels from inactivation, limiting high-frequency repetitive firing. The AAN/AES 2018 new-onset epilepsy guideline supports lamotrigine (particularly in older adults) and levetiracetam as effective initial monotherapy for focal epilepsy.
  • SV2A ligands: levetiracetam or brivaracetam modulate synaptic vesicle protein 2A, reducing excitatory transmitter release; favored for rapid titration and minimal interactions.
  • Escalation: switch to a second monotherapy before adding drugs; adjunctive options include lacosamide, perampanel (AMPA antagonist), topiramate, zonisamide, or eslicarbazepine.

Drug-resistant disease

  • Definition (ILAE 2010): failure of two appropriately chosen, adequately dosed, tolerated ASMs. Refer to a comprehensive epilepsy center rather than adding a third drug.
  • Anteromesial temporal lobectomy with amygdalohippocampectomy: the AAN 2003 practice parameter, based on a randomized trial, found resection superior to continued medical therapy for mesial TLE. Presurgical video-EEG, MRI, PET, neuropsychometry, and Wada/fMRI language-memory testing precede surgery.
  • Alternatives: MRI-guided laser interstitial thermal therapy, responsive neurostimulation, vagus nerve stimulation, thalamic DBS, or ketogenic/modified Atkins diet.

Contraindicated / avoid

  • Valproate in pregnancy or those who may become pregnant (neural tube defects, reduced childhood IQ) — avoid per AAN/ACOG guidance; supplement folic acid.
  • Carbamazepine without HLA-B*15:02 testing in patients of Southeast Asian ancestry (FDA labeling) because of SJS/TEN risk.
  • Abrupt ASM withdrawal, which precipitates status epilepticus.

Disease-related

  • Status epilepticus (emergency): sustained excitotoxic firing with GABA-A receptor internalization makes seizures progressively benzodiazepine-refractory; signaled by continuous seizure ≥5 minutes or failure to regain awareness between events.
  • Sudden unexpected death in epilepsy (SUDEP): postictal central apnea, autonomic instability, and cardiac arrhythmia after generalized tonic-clonic seizures; the AAN/AES 2017 guideline identifies frequent generalized tonic-clonic seizures as the dominant modifiable risk factor and estimates roughly 1 per 1,000 adult patient-years. Nocturnal, unwitnessed, prone deaths are typical.
  • Progressive memory impairment: cumulative hippocampal neuronal loss; dominant (usually left) foci degrade verbal memory, non-dominant foci visuospatial memory.
  • Psychiatric morbidity: depression, anxiety, and elevated suicide risk; postictal psychosis classically follows a lucid interval of hours to days after a seizure cluster and remits within days — an emergency when the patient is agitated or suicidal.
  • Injury and aspiration: falls, burns, drowning, posterior shoulder dislocation, and aspiration pneumonia from impaired-awareness episodes.

Treatment-related

  • Carbamazepine/oxcarbazepine: hyponatremia via SIADH-like effect (falling sodium, confusion, breakthrough seizures); carbamazepine also causes agranulocytosis/aplastic anemia and HLA-B*15:02-linked SJS/TEN (emergency — mucosal erosions, skin sloughing).
  • Lamotrigine: rash progressing to SJS, greatly increased by rapid titration or co-administered valproate, which inhibits its glucuronidation — any rash mandates stopping the drug.
  • Levetiracetam: irritability, aggression, and rarely psychosis; pyridoxine is sometimes trialed.
  • Valproate: hepatotoxicity, pancreatitis, hyperammonemic encephalopathy, thrombocytopenia, teratogenicity.
  • Topiramate/zonisamide: carbonic anhydrase inhibition → nephrolithiasis, metabolic acidosis, oligohidrosis; topiramate can cause acute angle-closure glaucoma (emergency — acute painful red eye, blurred vision).
  • Enzyme-inducing ASMs: accelerated vitamin D and hormonal contraceptive metabolism → osteoporosis and contraceptive failure.
  • Surgical: contralateral superior quadrantanopia ("pie in the sky") from Meyer's loop injury, and verbal memory decline after dominant temporal resection.

  • The classic triad in a stem: rising epigastric aura with déjà vu or sudden fear → impaired awareness with lip smacking and hand picking → prolonged postictal confusion. Long postictal confusion is what separates this from absence seizures.
  • Single best next step after a first unprovoked focal seizure: EEG plus MRI brain with a dedicated epilepsy protocol (thin coronal T2/FLAIR through the hippocampi). The finding is unilateral hippocampal atrophy with increased FLAIR signal and loss of internal architecture — mesial temporal sclerosis.
  • The association examiners test: prolonged or complex febrile seizures in early childhood preceding adult mesial TLE with hippocampal sclerosis.
  • A normal interictal EEG never excludes TLE. Anterior temporal spikes are best captured in sleep or on prolonged video-EEG; repeat/sleep-deprived studies raise yield.
  • Two failed appropriately chosen ASMs = drug-resistant epilepsy (ILAE) — the answer is referral to an epilepsy center for surgical evaluation, not a third drug. Anteromesial temporal lobectomy has the best seizure-freedom rates of any epilepsy surgery.
  • Lateralizing signs: ictal speech arrest/aphasia and postictal aphasia localize to the dominant (usually left) temporal lobe; contralateral dystonic limb posturing and ipsilateral postictal nose wiping are classic lateralizing clues.
  • Drug pitfalls: valproate is avoided in patients who may become pregnant (neural tube defects, reduced IQ); carbamazepine requires HLA-B*15:02 screening in patients of Southeast Asian ancestry; lamotrigine must be titrated slowly, especially with valproate.
  • Common distractors: absence seizures (no aura, no automatism-plus-confusion pattern, 3-Hz generalized spike-wave, provoked by hyperventilation, treated with ethosuximide) and psychogenic nonepileptic seizures (long duration, eyes forcibly closed, side-to-side head shaking, no postictal EEG slowing — diagnosed by video-EEG, not by prolactin).

Related topics

← Back to library